Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

UK researchers have analysed the likely impact that a Covid booster shot will have on Omicron and say it could provide around ...

Ongoing studies shows why covid 19 protection wanes over time. Know the factors behind waning immunity, why booster doses are ...

The absolute number of COVID-19 deaths was three times higher than those from flu, but the case-fatality ratio was comparable ...

Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe disease. But last month, the state of Florida issued updated vaccine guidance ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. The trial in ...

This latest vaccine protects against both earlier strains, including the Omicron variant, and the newly spreading JN1 variant, which has made its way around the globe, including Israel.

We asked experts about the new vaccines and what we can expect if they're approved. Professor Purcell said the first Omicron strain was an "escape" variant that required an updated vaccine.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons.